🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label trial to evaluate the safety, tolerability and immuno...
Status
Completed
Location
Central Kentucky Research Associates
Start Date
2020-04-03
Trial ID
NCT04336410
Treatments Being Tested
This is an open label, phase 1 clinical trial of an intra-dermal booster do...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-10
Trial ID
NCT05430958
Treatments Being Tested
The central premise of our program is that durable control of HIV in the ab...
Status
Completed
Location
University of California, Los Angeles
Start Date
2018-08-01
Trial ID
NCT03606213
Treatments Being Tested
This is a phase I/IIa trial to evaluate the safety, tolerability and immuno...
Status
Completed
Location
Seoul National University Bundang Hospital
Start Date
2020-07-15
Trial ID
NCT04447781
Treatments Being Tested
This is a single-arm, open-label, multi-site Phase I/IIa study of a persona...
Status
Active Not Recruiting
Location
Johns Hopkins Hospital
Start Date
2020-03-01
Trial ID
NCT04251117
Treatments Being Tested
This is a Phase 1b/2a, open-label, multi-center study to evaluate the safet...
Status
Completed
Location
Research Site
Start Date
2017-06-26
Trial ID
NCT03162224
Treatments Being Tested
The Middle East Respiratory Syndrome Coronavirus (MERS CoV), is a cause of ...
Status
Completed
Location
Seoul National University Bundang Hospital
Start Date
2018-08-28
Trial ID
NCT03721718
Treatments Being Tested
This is a Phase 1/2 open-label, multicenter trial to evaluate the safety, t...
Status
Completed
Location
Mayo Clinic Arizona
Start Date
2020-10-07
Trial ID
NCT04398433
Treatments Being Tested
This is a Phase 1, open-label, single center, dose escalation study to eval...
Status
Completed
Location
University of Pennsylvania
Start Date
2022-05-19
Trial ID
NCT05293249
This is a Phase 2/3, randomized, placebo-controlled, multi-center trial to ...
Status
Terminated
Location
Synexus Clinical Research US, Inc - Phoenix Southeast
Start Date
2020-11-30
Trial ID
NCT04642638
Treatments Being Tested